Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC, a biopharmaceutical firm focused on enhancing therapies for healthier lives, has published its 2023 Annual Report and Accounts, with plans for an AGM on June 28, 2024, in London. These documents are now accessible for shareholders and interested parties on the company’s website. Arecor continues to develop its portfolio of proprietary products and partner with industry leaders to advance therapeutic products using its Arestat™ technology platform.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
